Breakdown | ||||
Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
---|---|---|---|---|
Income Statement | Total Revenue | |||
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | Gross Profit |
0.00 | 0.00 | 0.00 | 0.00 | 0.00 | EBIT |
-421.15K | -1.04M | -483.50K | -238.37K | -155.37K | EBITDA |
-417.87K | -981.84K | -494.12K | -223.35K | 0.00 | Net Income Common Stockholders |
-426.33K | -982.96K | -503.81K | -257.52K | -60.70K |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | |||
31.56K | 222.47K | 1.11M | 321.68K | 2.62K | Total Assets |
37.45K | 242.45K | 5.05M | 3.09M | 2.44M | Total Debt |
11.41K | 13.96K | 11.55K | 240.99K | 252.24K | Net Debt |
1.37K | -12.29K | -698.43K | -80.69K | 249.62K | Total Liabilities |
371.85K | 150.52K | 223.13K | 759.34K | 850.77K | Stockholders Equity |
-334.40K | 91.93K | 4.83M | 2.33M | 1.59M |
Cash Flow | Free Cash Flow | |||
-190.60K | -1.70M | -1.53M | -254.92K | -145.95K | Operating Cash Flow |
-190.60K | -891.91K | -243.09K | 110.79K | -94.85K | Investing Cash Flow |
177.50K | 204.99K | -1.63M | -308.99K | 65.70K | Financing Cash Flow |
-3.11K | 736.00 | 2.27M | 517.25K | 29.98K |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
81 Outperform | C$2.95B | 19.06 | 26.82% | ― | 77.93% | 236.93% | |
78 Outperform | C$2.40B | 17.66 | 27.15% | ― | 67.54% | ― | |
56 Neutral | $6.99B | 3.76 | -4.38% | 5.90% | -0.24% | -48.46% | |
35 Underperform | $2.60M | ― | -2.96% | ― | ― | 84.13% | |
27 Underperform | $221.41M | ― | -22.20% | ― | ― | 0.84% | |
26 Underperform | C$1.35M | ― | -31.33% | ― | ― | -284.00% |